The mainstream news media never ceases to amaze me — and for all the wrong reasons.
When there’s nothing to report, they over-hype what drivel they have to the point where sensations arise from nothing.
Exhibit A: Kim Kardashian’s recent headline-grabbing, heavily oiled bid for renewed line-cutting privileges at the Mondrian Hotel’s Sky Bar in West Hollywood.
Exhibit B: Russell Brand’s ongoing campaign for the title of 21st Century Multi-Millionaire Celebrity Jesus.
And when there really is a significant story in the works, they just walk right past it, whistling blissfully, looking for the next big celebrity scandal to tout.
When it comes to Ebola, the modern-day Max Headroom types who man the news desks at the major networks have been a bit schizophrenic.
When the first breakout scares started cropping up earlier this fall, they had the nation captivated…
Glued to their seats with fear and panic.
In other words, engaged and entertained.
Even I fell into the trap as one of the patients — the pretty young nurse — was airlifted to the NIH campus just a few miles from where I live.
But then people got used to the stories and, predictably, got bored.
So now the media has turned back to its other favorite topics, tyrants, and terrorists to keep the masses planted on their butts, staring wide-eyed into the screens.
Silent Extinctions Are Nature’s Way of Saying Enough is Enough
But when it comes to threats to humanity — to the very way you and I live our daily lives — there hasn’t been, nor will there soon be, a more important story than Ebola (or the host of other infectious diseases emerging in the world every day).
What most people don’t know or try not to think about is that mass epidemics are inevitable — just like earthquakes, asteroids, and any other natural disaster.
Viruses are constantly evolving, and an antibiotic-resistant super-strain is never more than a few mutations away from turning a previously common sickness like the cold into a plague, like the influenza virus that killed as many as 5% of the world’s population just last century.
To make matters worse, with rampant overpopulation affecting many of the poorest regions in the world, old diseases, long thought extinct, are returning to do what diseases do best: cut down the population.
Just three weeks ago, an outbreak of Bubonic plague swept through Madagascar, claiming 40 lives and infecting many others.
When the Bubonic plague last visited Europe, it came to be known as the Black Death, as it killed between 30% and 60% of the population in the mid-14th century.
As the global population grows larger, it also accelerates its rate of growth — making outbreaks like this inevitably more and more common the farther along we get.
Worst of all, even if we cure one of these potential society-destroying diseases, we’re still just another few mutations away from the next big killer…
And just one unknown, asymptomatic carrier away from a full-fledged outbreak.
Think about it: A man with a MERS infection could be getting off a plane right now at an international airport just a few miles from your home, and none of us would know about it until it is too late.
A woman with a recently evolved airborne strain of Ebola might well be in a metro car riding under the streets of Washington, D.C. right this minute — and to anybody else onboard, she’d just look and sound like someone with a seasonal cold.
There is no way to defeat all infectious threats from a pharmacological standpoint, but right now, a new kind of solution to this threat may have just emerged from the labs of a small Michigan-based company.
Plus receive our new free report, Predicting the VIX Moves
E-mail Address:
Wealth Daily Members Receive:
- Daily commentary and advice from financial market experts.
- Access to some of the best gold, silver, and option stock picks around.
- Foresight designed to help you stay on top of the market.
After getting your report, you’ll begin receiving the Wealth Daily e-Letter, delivered to your inbox daily.
An Ounce of Prevention Could Stop an Epidemic
It’s not a medicine. The company doesn’t make pharmaceuticals. In fact, what it makes isn’t even covered by the FDA.
But the solution it’s found has the power to cut off and kill any would-be epidemic before it has a chance to spread.
This technology is nothing short of game changing in the way it treats threats like Ebola, MERS, avian flu, influenza, or any other pandemic-caliber disease.
And it’s already being installed in the some of the nation’s best hospitals.
Among them, the world-renowned Johns Hopkins Hospital in Baltimore.
Of course, you’re not going to see the mainstream news report on this, even though it could very well stop the next history-altering outbreak from hitting our major population centers.
But don’t let that bother you.
For the full backstory on this technology, real accounts of how it’s already worked, and, of course, all the information on the company that’s doing it…
Fortune favors the bold,
Alex Koyfman
Check us out on YouTube!His flagship service, Microcap Insider, provides market-beating insights into some of the fastest moving, highest profit-potential companies available for public trading on the U.S. and Canadian exchanges. With more than 5 years of track record to back it up, Microcap Insider is the choice for the growth-minded investor. Alex contributes his thoughts and insights regularly to Energy and Capital. To learn more about Alex, click here.
